These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9154026)

  • 1. Is the clinical course of HIV-1 changing? Cohort study.
    Sinicco A; Fora R; Raiteri R; Sciandra M; Bechis G; Calvo MM; Gioannini P
    BMJ; 1997 Apr; 314(7089):1232-7. PubMed ID: 9154026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.
    Cozzi Lepri A; Pezzotti P; Dorrucci M; Phillips AN; Rezza G
    BMJ; 1994 Dec; 309(6968):1537-42. PubMed ID: 7819892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.
    Maas JJ; Dukers N; Krol A; van Ameijden EJ; van Leeuwen R; Roos MT; de Wolf F; Coutinho RA; Keet IP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):254-9. PubMed ID: 9803967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.
    Touloumi G; Karafoulidou A; Gialeraki A; Katsarou O; Milona I; Kapsimali V; Mandalaki T; Hatzakis A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):89-97. PubMed ID: 9732075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study.
    Phillips AN; Pezzotti P; Lepri AC; Rezza G
    AIDS; 1994 Sep; 8(9):1299-305. PubMed ID: 7802984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.
    Burack JH; Barrett DC; Stall RD; Chesney MA; Ekstrand ML; Coates TJ
    JAMA; 1993 Dec; 270(21):2568-73. PubMed ID: 7901433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002.
    Dorrucci M; Phillips AN; Longo B; Rezza G;
    AIDS; 2005 Feb; 19(3):331-5. PubMed ID: 15718844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort Study.
    Touloumi G; Hatzakis A; Rosenberg PS; O'Brien TR; Goedert JJ
    AIDS; 1998 Sep; 12(13):1691-7. PubMed ID: 9764790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
    Margolick JB; Muñoz A; Vlahov D; Solomon L; Astemborski J; Cohn S; Nelson KE
    JAMA; 1992 Mar; 267(12):1631-6. PubMed ID: 1347321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term HIV-1 infection without immunologic progression.
    Buchbinder SP; Katz MH; Hessol NA; O'Malley PM; Holmberg SD
    AIDS; 1994 Aug; 8(8):1123-8. PubMed ID: 7986410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.
    CASCADE Collaboration
    J Acquir Immune Defic Syndr; 2003 Sep; 34(1):76-83. PubMed ID: 14501798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection.
    van Asten L; Danisman F; Otto SA; Borghans JA; Hazenberg MD; Coutinho RA; Prins M; Miedema F
    AIDS; 2004 Sep; 18(14):1885-93. PubMed ID: 15353974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.
    Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
    BMJ; 1994 Jul; 309(6950):309-13. PubMed ID: 7916226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How soon after HIV seroconversion is antiretroviral therapy initiated? The UK Register of HIV Seroconverters Steering Committee.
    AIDS; 1999 Jul; 13(10):1241-7. PubMed ID: 10416529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the effect of antiretroviral treatment during HIV seroconversion: impact of confounding in observational data.
    Clements M; Law M; Pedersen C; Kaldor J;
    HIV Med; 2003 Oct; 4(4):332-7. PubMed ID: 14525545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rate of CD4 decline as a determinant of progression to AIDS independent of the most recent CD4 count. The Italian Seroconversion Study.
    Cozzi Lepri A; Sabin CA; Phillips AN; Lee CA; Pezzotti P; Rezza G
    Epidemiol Infect; 1998 Oct; 121(2):369-76. PubMed ID: 9825787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines.
    Lodi S; Phillips A; Touloumi G; Geskus R; Meyer L; Thiébaut R; Pantazis N; Amo JD; Johnson AM; Babiker A; Porter K;
    Clin Infect Dis; 2011 Oct; 53(8):817-25. PubMed ID: 21921225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.